Key Drivers
- High profitability
- Negative FCF
- Heavy leverage
AIAI Summary
HTGC's investment case has shifted from a credit‑driven yield play to a capital‑markets/reputational trade—litigation headlines, elevated short interest and negative free cash flow (despite strong underlying credit metrics) now drive valuation and funding access. Actionable: treat HTGC as event‑driven, not a core buy, and monitor legal resolution, a move to positive FCF or credible dividend alignment, and any spikes in funding costs as the decisive catalysts.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High profitability
- •Negative FCF
- •Heavy leverage
HTGC delivers high margins, strong ROE and a generous dividend supported by a large investment portfolio, but heavy leverage, negative free cash flow, tiny cash reserves and reliance on debt to fund payouts create meaningful liquidity and sustainability risks.
Price Behavior
Key Price Behavior Insights:
- •Below SMA
- •Near support
- •Failed retake
HTGC has slipped into a mild short-term downtrend over the last month (price below its last-month SMA) trading between near-term resistance ~$15.43 and support ~$14.04 with a neutral-to-slightly weak 14-day RSI (~43) that leaves room for a rebound but favors sellers unless price reclaims resistance.
Price failed to retake $15.43 and has drifted below last-month
Sentiment & News
Key News Insights:
- •Hunterbrook trigger
- •Multiple law firms
- •Strong credit metrics
Hercules Capital faces a split narrative after a Hunterbrook report alleging misleading loss metrics triggered multiple securities‑fraud probes while analysts point to strong credit metrics and industry accolades, creating litigation risk despite solid fundamentals.
Short‑term share volatility and heightened legal overhang are likely despite underlying credit strength, making HTGC a higher‑risk, potentially opportunistic play
Similar Companies in Financial Services
Other companies in the same sector with AI ratings